Abstract
BMP4 variants have been reported to be associated with syndromic microphthalmia (MCOPS6, OMIM 607932). This study aims to describe BMP4 truncation mutations contributing to a novel phenotype in eight patients from four Chinese families. In this study, BMP4 variants were collected from a large dataset from in-house exome sequencing. Candidate variants were filtered by multiple in silico tools as well as comparison with data from multiple databases. Potential pathogenic variants were further confirmed by Sanger sequencing and cosegregation analysis. Four novel truncation variants in BMP4 were detected in four out of 7,314 unrelated probands with different eye conditions. These four mutations in the four families solely cosegregated in all eight patients with a specific form of pathologic myopia, characterized by significantly extended axial length, posterior staphyloma, macula patchy, chorioretinal atrophy, myopic optic neuropathy or glaucoma, vitreous opacity, and unique peripheral snow-grain retinopathy. The extreme rarity of the truncations in BMP4 (classified as intolerant in the gnomAD database, pLI = 0.96), the exclusive presence of these variants in the four families with pathologic myopia, variants fully co-segregated with the same specific phenotypes in eight patients from the four families, and the association of the pathogenicity of truncations with syndromic microphthalmia in previous studies, all support a novel association of BMP4 truncations with a specific form of pathologic myopia. The data presented in this study demonstrated that heterozygous BMP4 truncations contributed to a novel phenotype: pathologic myopia rather than microphthalmia. Mutations in the same gene resulting in both high myopia and microphthalmia have been observed for a few other genes like FZD5 and PAX6, suggesting bidirectional roles of these genes in early ocular development. Further studies are expected to elucidate the molecular mechanism of the bidirectional regulation.
Introduction
Pathologic myopia is a leading cause of legal blindness worldwide, characterized by excessive elongation of the eye's axial length. This stretching leads to progressive damage of the retina and choroid. While the genetic basis of myopia is complex, identifying specific regulatory genes is crucial for understanding ocular development.
Historically, the BMP4 gene has been linked to "small eye" syndromes, such as microphthalmia and coloboma, where eye growth is restricted. This study addresses a paradoxical discovery: truncation mutations in BMP4—a gene typically associated with restricted growth—can lead to the excessive eye growth seen in pathologic myopia.
Methods
The researchers utilized a multi-stage genomic and clinical approach to investigate a cohort of 7,314 unrelated Chinese probands. This cohort included 928 individuals with early-onset high myopia and 6,386 with other ocular conditions.
- Exome Sequencing & Bioinformatic Filtering: Whole-exome or target-exome sequencing identified rare variants. These were screened using in silico tools (SIFT, PolyPhen-2) and compared against the gnomAD database to assess rarity and gene intolerance (pLI score).
- Cosegregation Analysis: Sanger sequencing was employed to confirm that identified mutations tracked with the disease within affected families.
- Clinical Phenotyping: Patients underwent comprehensive exams, including axial length measurement, fundus photography, and optical coherence tomography (OCT).
- Immunohistochemistry: BMP4 protein expression was mapped in human donor retinas to determine its localization in the adult eye.
Results
The study identified four novel truncation mutations in BMP4: c.43delC, c.97A > T, c.419delT, and c.766C > T. These variants were found exclusively in 4 out of 928 high myopia patients and were absent in the 6,386 control patients ($P = 2.58 \times 10^{-4}$).
Affected individuals exhibited extreme phenotypes, with an average axial length of 30.62 mm (compared to a normal range of 23-24 mm), with some cases reaching nearly 38 mm. A unique clinical marker, "snow-grain" retinopathy (small white spots in the peripheral retina), was observed in these patients, potentially serving as a diagnostic indicator for BMP4-related myopia.
Cosegregation analysis confirmed that these mutations were present in all affected family members and absent in healthy relatives, reinforcing the pathogenic link between BMP4 truncations and pathologic myopia.
Discussion
The most significant finding is the "bidirectional" role of BMP4 in ocular development. Similar to a thermostat, BMP4 appears to regulate ocular scale in both directions. Depending on the specific mutation or developmental context, loss of function can result in an eye that is either abnormally small (microphthalmia) or abnormally large (pathologic myopia). This phenomenon has been observed in other genes like FZD5 and PAX6, suggesting a shared regulatory logic in eye size determination.
While the genetic association is robust, the exact molecular mechanism remains to be elucidated. The high pLI score (0.96) for BMP4 indicates that the human genome is highly intolerant to these mutations, highlighting the gene's critical role. Future research using animal models (e.g., CRISPR-edited zebrafish or mice) is necessary to replicate this bidirectional growth and identify the developmental "switch" that determines the final ocular phenotype.
Summary updated